Institution
Bezmialem Foundation University
Education•Istanbul, Turkey•
About: Bezmialem Foundation University is a education organization based out in Istanbul, Turkey. It is known for research contribution in the topics: Medicine & Population. The organization has 1490 authors who have published 3516 publications receiving 33806 citations.
Topics: Medicine, Population, Cancer, Anxiety, Myocardial infarction
Papers
More filters
Guy's and St Thomas' NHS Foundation Trust1, John Radcliffe Hospital2, University of Nottingham3, Brigham and Women's Hospital4, ISMETT5, Banaras Hindu University6, Newton Wellesley Hospital7, Madras Institute of Orthopaedics and Traumatology8, University of the West Indies9, University of Michigan10, Sahlgrenska University Hospital11, Queen Mary University of London12, Aga Khan University13, University of Manchester14, Virginia Commonwealth University15, University of Padua16, Changi General Hospital17, King's College London18, Southampton General Hospital19, Texas Tech University Health Sciences Center20, McMaster University21, University Hospital Waterford22, Turku University Hospital23, University of Mainz24, Bezmialem Foundation University25, Colchester Hospital University NHS Foundation Trust26, Kent State University27, Guy's Hospital28, Cairo University29, Children's of Alabama30
TL;DR: The development of the STROCSS guideline (Strengthening the Reporting of Cohort Studies in Surgery), consisting of a 17-item checklist, is described and it is hoped its use will increase the transparency and reporting quality of such studies.
736 citations
Icahn School of Medicine at Mount Sinai1, University of Calgary2, Charles University in Prague3, Bezmialem Foundation University4, Medical University of Vienna5, Catholic University of the Sacred Heart6, University of Nice Sophia Antipolis7, University of Oxford8, Humanitas University9, University of California, San Diego10, Katholieke Universiteit Leuven11, University of California, Los Angeles12, AbbVie13, University of Amsterdam14
TL;DR: This trial aimed to compare endoscopic and clinical outcomes in patients with moderate to severe Crohn's disease who were managed with a tight control algorithm, using clinical symptoms and biomarkers, versus patients management with a clinical management algorithm.
575 citations
TL;DR: Determination of serum creatinine levels and urinalysis in patients with chronic kidney disease risk will usually be sufficient for initial screening, and this should be able to identify individuals with increased risk of renal disease.
386 citations
Başkent University1, Hacettepe University2, Istanbul Medeniyet University3, Dniepropetrovsk State Medical Academy4, Istanbul University5, Bezmialem Foundation University6, Trakya University7, Illawarra Health & Medical Research Institute8, Chulalongkorn University9, Columbia University Medical Center10, Regeneron11, Çukurova University12
TL;DR: In this paper, the first-line treatment of advanced non-small-cell lung cancer with programmed cell death ligand 1 (PD-L1) of at least 50% was examined in a multicentre, open-label, global, phase 3 study.
342 citations
Aarhus University Hospital1, Masaryk University2, University of Copenhagen3, King Saud University4, Jagiellonian University5, University of Latvia6, Bezmialem Foundation University7, Copenhagen University Hospital8, Uppsala University9, Charles University in Prague10, Health Service Executive11, National and Kapodistrian University of Athens12, Tel Aviv University13, University Hospitals Birmingham NHS Foundation Trust14, Semmelweis University15, University Hospital Centre Zagreb16, University of Zagreb17, University Medical Center18, University of Zurich19, Alexandria University20, Academy of Medical Sciences, United Kingdom21
TL;DR: Large variations in reperfusion treatment are still present across Europe, and countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusions therapy.
Abstract: Aims Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate the contemporary status on the use and type of reperfusion therapy in patients admitted with STEMI in the European Society of Cardiology (ESC) member countries.
Methods and results A cross-sectional descriptive study based on aggregated country-level data on the use of reperfusion therapy in patients admitted with STEMI during 2010 or 2011. Thirty-seven ESC countries were able to provide data from existing national or regional registries. In countries where no such registries exist, data were based on best expert estimates. Data were collected on the use of STEMI reperfusion treatment and mortality, the numbers of cardiologists, and the availability of PPCI facilities in each country. Our survey provides a brief data summary of the degree of variation in reperfusion therapy across Europe. The number of PPCI procedures varied between countries, ranging from 23 to 884 per million inhabitants. Primary percutaneous coronary intervention and thrombolysis were the dominant reperfusion strategy in 33 and 4 countries, respectively. The mean population served by a single PPCI centre with a 24-h service 7 days a week ranged from 31 300 inhabitants per centre to 6 533 000 inhabitants per centre. Twenty-seven of the total 37 countries participated in a former survey from 2007, and major increases in PPCI utilization were observed in 13 of these countries.
Conclusion Large variations in reperfusion treatment are still present across Europe. Countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusion therapy. Implementation of the best reperfusion therapy as recommended in the guidelines should be encouraged.
280 citations
Authors
Showing all 1519 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Javad Parvizi | 111 | 969 | 51075 |
| Ziyad M. Hijazi | 59 | 332 | 16324 |
| Ozgur Kasapcopur | 39 | 338 | 6698 |
| Abdurrahim Kocyigit | 37 | 202 | 4638 |
| Ulkan Kilic | 37 | 101 | 4594 |
| Murat Kartal | 36 | 122 | 4084 |
| Gulacti Topcu | 35 | 204 | 4953 |
| Mustafa Ozen | 35 | 96 | 4955 |
| Ahmet C. Gören | 31 | 156 | 3566 |
| Hakan Senturk | 31 | 163 | 4249 |
| Aslihan Usumez | 30 | 118 | 2975 |
| Omer Uysal | 30 | 176 | 3327 |
| Ahmet Yaser Muslumanoglu | 29 | 84 | 2661 |
| Huseyin Uyarel | 28 | 169 | 2909 |
| Zehra Durmus | 28 | 76 | 2104 |